Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 254 articles:
HTML format
Text format



Single Articles


    September 2019
  1. ULLMANN TM, Gray KD, Limberg J, Stefanova D, et al
    Insurance Status Affects Extent of Treatment for Patients with Papillary Thyroid Carcinoma.
    Thyroid. 2019 Sep 10. doi: 10.1089/thy.2019.0245.
    PubMed     Text format     Abstract available


    August 2019
  2. CHUNG JH, Park J, Kim JW, Park H, et al
    Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
    Thyroid. 2019 Aug 30. doi: 10.1089/thy.2019.0261.
    PubMed     Text format     Abstract available


  3. HO AS, Luu M, Zalt C, Morris LGT, et al
    Mortality risk of nonoperative papillary thyroid carcinoma: a corollary for active surveillance.
    Thyroid. 2019 Aug 13. doi: 10.1089/thy.2019.0060.
    PubMed     Text format     Abstract available


  4. BORRELLI N, Panebianco F, Condello V, Barletta JA, et al
    Characterization of activating mutations of the <i>MEK1</i> gene in papillary thyroid carcinomas.
    Thyroid. 2019 Aug 13. doi: 10.1089/thy.2019.0065.
    PubMed     Text format     Abstract available


  5. WONG KS, Lorch J, Alexander EK, Marqusee E, et al
    Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.
    Thyroid. 2019 Aug 9. doi: 10.1089/thy.2019.0263.
    PubMed     Text format     Abstract available


    July 2019
  6. QI XP, Jin BY, Li PF, Wang S, et al
    RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.
    Thyroid. 2019 Jul 31. doi: 10.1089/thy.2018.0385.
    PubMed     Text format     Abstract available


  7. SHI X, Yu PC, Lei BW, Li CW, et al
    The Association between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence and Biochemical Recurrence/Persistent Disease in Medullary Thyroid Carcinoma.
    Thyroid. 2019 Jul 20. doi: 10.1089/thy.2019.0079.
    PubMed     Text format     Abstract available


  8. WANG JR, Zafereo M, Dadu R, Ferrarotto R, et al
    Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0133.
    PubMed     Text format     Abstract available


  9. ITO Y, Ishikawa H, Kihara M, Hirokawa M, et al
    Control of lung metastases and colon polyposis with lenvatinib therapy in a patient with cribriform-morular variant of papillary thyroid carcinoma and an APC gene mutation: a case study.
    Thyroid. 2019 Jul 18. doi: 10.1089/thy.2019.0121.
    PubMed     Text format     Abstract available


  10. TANAKA A, Matsuse M, Saenko VA, Nakao T, et al
    TERT mRNA expression as a novel prognostic marker in papillary thyroid carcinomas.
    Thyroid. 2019 Jul 9. doi: 10.1089/thy.2018.0695.
    PubMed     Text format     Abstract available


    May 2019
  11. IZKHAKOV E, Vaisman N, Barnes S, Barchana M, et al
    Body composition, resting energy expenditure and metabolic changes in women diagnosed with differentiated thyroid carcinoma.
    Thyroid. 2019 May 15. doi: 10.1089/thy.2018.0483.
    PubMed     Text format     Abstract available


  12. UCAL Y, Tokat F, Duren M, Ince U, et al
    Peptide Profile Differences of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features, Encapsulated Follicular Variant, and Classical Papillary Thyroid Carcinoma: An Application of MALDI Mass Spectrometry Imaging.
    Thyroid. 2019 May 8. doi: 10.1089/thy.2018.0392.
    PubMed     Text format     Abstract available


    April 2019
  13. KIM HI, Hyeon J, Park SY, Ahn HS, et al
    Impact of extranodal extension on risk stratification in papillary thyroid carcinoma.
    Thyroid. 2019 Apr 26. doi: 10.1089/thy.2018.0541.
    PubMed     Text format     Abstract available


  14. SCHURCH CM, Roelli MA, Forster S, Wasmer MH, et al
    Targeting CD47 in anaplastic thyroid carcinoma enhances tumor phagocytosis by macrophages and is a promising therapeutic strategy.
    Thyroid. 2019 Apr 2. doi: 10.1089/thy.2018.0555.
    PubMed     Text format     Abstract available


    March 2019
  15. JOO LJS, Weiss J, Gill AJ, Clifton-Bligh RJ, et al
    RET kinase-regulated microRNA-153-3p improves therapeutic efficacy in medullary thyroid carcinoma.
    Thyroid. 2019 Mar 30. doi: 10.1089/thy.2018.0525.
    PubMed     Text format     Abstract available


  16. TURK A, Asa SL, Baloch ZW, Faquin WC, et al
    Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New AJCC 8th Edition Criteria for Tumor Staging.
    Thyroid. 2019 Mar 27. doi: 10.1089/thy.2018.0286.
    PubMed     Text format     Abstract available


  17. JEONG JH, Oh JM, Jeong SY, Lee SW, et al
    Combination treatment with BRAFV600E inhibitor, vemurafenib, and BH3 mimetic, navitoclax, for BRAF mutant thyroid carcinoma.
    Thyroid. 2019 Mar 14. doi: 10.1089/thy.2018.0511.
    PubMed     Text format     Abstract available


  18. WONG KS, Lorch J, Alexander EK, Nehs MA, et al
    Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
    Thyroid. 2019 Mar 14. doi: 10.1089/thy.2018.0716.
    PubMed     Text format     Abstract available


  19. AHN J, Song E, Oh HS, Song DE, et al
    Low lymphocyte-to-monocyte ratios are associated with poor overall survival in anaplastic thyroid carcinoma patients.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0684.
    PubMed     Text format     Abstract available


  20. OH HS, Kwon H, Song E, Jeon M, et al
    Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma.
    Thyroid. 2019 Mar 13. doi: 10.1089/thy.2018.0609.
    PubMed     Text format     Abstract available


  21. YAISH I, Azem F, Tordjman KM
    Re: "Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study" by Evranos et al. (Thyroid 2018;28:1702-1707).
    Thyroid. 2019;29:453.
    PubMed     Text format    


    January 2019
  22. MATHIESEN JS, Kroustrup JP, Vestergaard P, Poulsen PL, et al
    Survival and long-term biochemical cure in medullary thyroid carcinoma in Denmark 1997-2014: A nationwide study.
    Thyroid. 2019 Jan 8. doi: 10.1089/thy.2018.0564.
    PubMed     Text format     Abstract available


    December 2018
  23. SAKAI T, Sugitani I, Ebina A, Fukuoka O, et al
    Active surveillance for T1bN0M0 papillary thyroid carcinoma.
    Thyroid. 2018 Dec 18. doi: 10.1089/thy.2018.0462.
    PubMed     Text format     Abstract available


    November 2018
  24. OH HS, Ahn J, Song E, Han JM, et al
    Individualized Follow-up Strategy for Patients with Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
    Thyroid. 2018 Nov 1. doi: 10.1089/thy.2018.0391.
    PubMed     Text format     Abstract available


    October 2018
  25. SONG E, Han M, Oh HS, Kim WW, et al
    Lobectomy is feasible for papillary thyroid carcinomas sized 1-4 cm: A 10-year propensity score matched pair analysis on recurrence.
    Thyroid. 2018 Oct 30. doi: 10.1089/thy.2018.0554.
    PubMed     Text format     Abstract available


  26. SONG E, Lee YM, Oh HS, Jeon M, et al
    A relook at the T stage of differentiated thyroid carcinoma: focus on gross extrathyroidal extension.
    Thyroid. 2018 Oct 25. doi: 10.1089/thy.2018.0300.
    PubMed     Text format     Abstract available


  27. HA EJ, Na DG, Moon WJ, Lee Y, et al
    Diagnostic Performance of Ultrasound-based Risk Stratification Systems for Thyroid Nodules: Comparison of the 2015 ATA guidelines with the 2016 KTA/KSThR and 2017 ACR guidelines.
    Thyroid. 2018 Oct 12. doi: 10.1089/thy.2018.0094.
    PubMed     Text format     Abstract available


  28. MCIVER B, Freeman JL, Shah JP, Shaha AR MD, et al
    Summary of the third World Congress on Thyroid Cancer.
    Thyroid. 2018 Oct 10. doi: 10.1089/thy.2018.0616.
    PubMed     Text format     Abstract available


    September 2018
  29. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a prospective Swedish population-based study.
    Thyroid. 2018 Sep 22. doi: 10.1089/thy.2018.0388.
    PubMed     Text format     Abstract available


  30. MAHAJAN P, Dawrant J, Kheradpour A, Quintanilla NM, et al
    Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0064.
    PubMed     Text format     Abstract available


  31. SONG YS, Won JK, Yoo SK, Jung KC, et al
    Comprehensive transcriptomic and genomic profiling of subtypes of follicular variant of papillary thyroid carcinoma.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0198.
    PubMed     Text format     Abstract available


  32. KIM TM, Kim JH, Yoo RE, Kim SC, et al
    Persistent/Recurrent Differentiated Thyroid Cancer: Clinical and Radiological Characteristics of Persistent Disease and Clinical Recurrence Based on Computed Tomography Analysis.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0151.
    PubMed     Text format     Abstract available


  33. SIM JS, Baek JH, Cho W
    Initial Ablation Ratio: Quantitative Value Predicting the Therapeutic Success of Thyroid Radiofrequency Ablation.
    Thyroid. 2018 Sep 18. doi: 10.1089/thy.2018.0180.
    PubMed     Text format     Abstract available


  34. LIN JD, Liou MJ, Hsu HL, Leong KK, et al
    Circulating Epithelial Cell Characterization and Correlation with Remission and Survival in Patients with Thyroid Cancer.
    Thyroid. 2018 Sep 15. doi: 10.1089/thy.2017.0639.
    PubMed     Text format     Abstract available


  35. CARR AA, Yen T, Ortiz DI, Hunt BC, et al
    Oncocytic papillary thyroid cancer has similar prognosis to matched classical papillary thyroid cancer controls.
    Thyroid. 2018 Sep 14. doi: 10.1089/thy.2017.0603.
    PubMed     Text format     Abstract available


    August 2018
  36. TAM S, Boonsripitayanon M, Amit M, Fellman BM, et al
    Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2017.0572.
    PubMed     Text format     Abstract available


  37. SUN Y, Du F, Gao M, Ji QH, et al
    Anlotinib for the Treatment of Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2018.0022.
    PubMed     Text format     Abstract available


  38. JAESCHKE H, Undeutsch H, Patyra K, Lof C, et al
    Hyperthyroidism and papillary thyroid carcinoma in thyrotropin receptor D633H mutant mice.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2018.0041.
    PubMed     Text format     Abstract available


  39. RAGO T, Scutari M, Loiacono V, Tonacchera M, et al
    Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology.
    Thyroid. 2018 Aug 22. doi: 10.1089/thy.2017.0522.
    PubMed     Text format     Abstract available


  40. KIM SJ, Lee SW, Jeong SY, Pak K, et al
    Diagnostic Performance of Tc-99m MIBI for Differentiation of Malignant Thyroid Nodules; A Systematic Review and Meta-analysis.
    Thyroid. 2018 Aug 21. doi: 10.1089/thy.2018.0072.
    PubMed     Text format     Abstract available


  41. ZANELLA AB, Scheffel RS, Nava CF, Golbert L, et al
    Dynamic Risk Stratification in the Follow-up of Children and Adolescents with Differentiated Thyroid Cancer.
    Thyroid. 2018 Aug 21. doi: 10.1089/thy.2018.0075.
    PubMed     Text format     Abstract available


  42. DAVIES L, Haymart MR
    South Korean Thyroid Cancer Trends: Good news and bad.
    Thyroid. 2018 Aug 16. doi: 10.1089/thy.2018.0508.
    PubMed     Text format     Abstract available


  43. BORSON-CHAZOT F, Dantony E, Illouz F, Lopez J, et al
    Effect of Buparlisib, a pan-class I PI3K inhibitor, in refractory follicular and poorly differentiated thyroid cancer.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2017.0663.
    PubMed     Text format     Abstract available


  44. GRANI G, Lamartina L, Biffoni M, Giacomelli L, et al
    Sonographically estimated risks of malignancy for thyroid nodules computed with five standard classification systems: changes over time and their relation to malignancy.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0178.
    PubMed     Text format     Abstract available


  45. BECKHAM TH, Romesser PB, Groen AH, Sabol C, et al
    Intensity Modulated Radiation Therapy with or without Concurrent Chemotherapy in Non-Anaplastic Thyroid Cancer with Unresectable or Gross Residual Disease.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0214.
    PubMed     Text format     Abstract available


  46. VAN NOSTRAND D
    Radioiodine Refractory Differentiated Thyroid Cancer: Time to Update the Classifications.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2018.0048.
    PubMed     Text format     Abstract available


  47. LLAMAS-OLIER A, Cuellar DI, Buitrago G
    Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Thyroid. 2018 Aug 14. doi: 10.1089/thy.2017.0578.
    PubMed     Text format     Abstract available


    July 2018
  48. DANIELS GH
    Follicular Thyroid Carcinoma: A Perspective.
    Thyroid. 2018 Jul 24. doi: 10.1089/thy.2018.0306.
    PubMed     Text format     Abstract available


  49. BOGDANOVA TI, Saenko VA, Brenner AV, Zurnadzhy LY, et al
    Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident.
    Thyroid. 2018;28:880-890.
    PubMed     Text format     Abstract available


    June 2018
  50. MA B, Wei WJ, Xu W, Wang Y, et al
    Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation: A retrospective case review and literature review.
    Thyroid. 2018 Jun 30. doi: 10.1089/thy.2017.0558.
    PubMed     Text format     Abstract available


  51. SCHMIDT JENSEN J, Gronhoj C, Mirian C, Jensen DH, et al
    Incidence and survival of thyroid cancer in children, adolescents, and young adults in Denmark: a nation-wide study from 1980 to 2014.
    Thyroid. 2018 Jun 26. doi: 10.1089/thy.2018.0067.
    PubMed     Text format     Abstract available


  52. TAM S, Amit M, Boonsripitayanon M, Busaidy N, et al
    The Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2018 Jun 23. doi: 10.1089/thy.2017.0513.
    PubMed     Text format     Abstract available


  53. SEMRAD TJ, Keegan T, Semrad AM, Brunson A, et al
    Predictors of Neck Reoperation and Mortality after Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Thyroid. 2018 Jun 21. doi: 10.1089/thy.2017.0483.
    PubMed     Text format     Abstract available


  54. TRAN BM, Roshan DJ, Abraham E, Wang LY, et al
    The Prognostic Impact of Tumor Size in Papillary Thyroid Carcinoma is Modified by Age.
    Thyroid. 2018 Jun 19. doi: 10.1089/thy.2017.0607.
    PubMed     Text format     Abstract available


  55. BRITO JP, Moon JH, Zeuren R, Kong SH, et al
    Thyroid Cancer Treatment Choice: A pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options.
    Thyroid. 2018 Jun 15. doi: 10.1089/thy.2018.0105.
    PubMed     Text format     Abstract available


  56. LIANG JY, Huang XW, Hu HT, Liu YH, et al
    <b>Predicting Malignancy in Thyroid Nodules: Radiomics Score versus 2017 American College of Radiology (ACR) Thyroid Imaging, Reporting and Data System (TI-RADS)</b>.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2017.0525.
    PubMed     Text format     Abstract available


  57. JEON M, Kim HK, Kim EH, Kim ES, et al
    Decreasing Disease-specific Mortality of Differentiated Thyroid Cancer in Korea: A Multicenter Cohort Study.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2018.0159.
    PubMed     Text format     Abstract available


  58. GHAZNAVI SA, Ganly I, Shaha AR MD, English CL, et al
    Using the ATA risk stratification system to refine and individualize the AJCC 8th edition disease specific survival estimates in differentiated thyroid cancer.
    Thyroid. 2018 Jun 13. doi: 10.1089/thy.2018.0186.
    PubMed     Text format     Abstract available


  59. HUK D, Ashtekar A, Magner A, La Perle K, et al
    Deletion of Rap1b, but not Rap1a or Epac1, reduces PKA-mediated thyroid cancer.
    Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0528.
    PubMed     Text format     Abstract available


  60. HUANG Y, Yu S, Cao S, Yin Y, et al
    MicroRNA-222 promotes invasion and metastasis of papillary thyroid cancer through targeting protein phosphatase 2 regulatory subunit B alpha expression.
    Thyroid. 2018 Jun 8. doi: 10.1089/thy.2017.0665.
    PubMed     Text format     Abstract available


  61. MATRONE A, Latrofa F, Torregrossa L, Piaggi P, et al
    Changing trend of thyroglobulin antibodies in not 131I ablated differentiated thyroid cancer patients.
    Thyroid. 2018 Jun 2. doi: 10.1089/thy.2018.0080.
    PubMed     Text format     Abstract available


    May 2018
  62. VAN VELSEN EFS, Stegenga M, van Kemenade FJ, Kam B, et al
    Comparing the Prognostic Value of the Eighth Edition of the AJCC/TNM Staging System between Papillary and Follicular Thyroid Cancer.
    Thyroid. 2018 May 31. doi: 10.1089/thy.2018.0066.
    PubMed     Text format     Abstract available


  63. VALDERRABANO P, McGettigan MJ, Lam C, Khazai L, et al
    Thyroid nodules with indeterminate cytology: Utility of the American Thyroid Association sonographic patterns for cancer risk stratification.
    Thyroid. 2018 May 31. doi: 10.1089/thy.2018.0085.
    PubMed     Text format     Abstract available


  64. PARK S, Jeon M, Oh HS, Lee YM, et al
    Changes in Serum Thyroglobulin Levels after Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer.
    Thyroid. 2018 May 30. doi: 10.1089/thy.2018.0046.
    PubMed     Text format     Abstract available


  65. CHO YY, Kang MJ, Kim SK, Jung J, et al
    Protective Effect of Metformin against Thyroid Cancer Development: a Population-based Study in Korea.
    Thyroid. 2018 May 29. doi: 10.1089/thy.2017.0550.
    PubMed     Text format     Abstract available


  66. WANG T, Jiang M, Ren Y, Liu Q, et al
    Health-related quality of life of community thyroid cancer survivors in Hangzhou, China.
    Thyroid. 2018 May 29. doi: 10.1089/thy.2017.0213.
    PubMed     Text format     Abstract available


  67. OWEIDA AJ, Phan A, Vancourt B, Robin T, et al
    Hypofractionated radiotherapy is superior to conventional fractionation in an orthotopic model of anaplastic thyroid cancer.
    Thyroid. 2018 May 18. doi: 10.1089/thy.2017.0706.
    PubMed     Text format     Abstract available


  68. HE H, Li W, Yan P, Bundschuh R, et al
    Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
    Thyroid. 2018 May 16. doi: 10.1089/thy.2017.0258.
    PubMed     Text format     Abstract available


  69. CHUNG SR, Choi YJ, Suh CH, Kim HJ, et al
    Thyroid incidentalomas detected on 18F-FDG PET/CT: Malignant risk stratification and management plan.
    Thyroid. 2018 May 15. doi: 10.1089/thy.2017.0560.
    PubMed     Text format     Abstract available


  70. CHU KP, Baker SP, Zenke JK, Morad A, et al
    Low-Activity Radioactive Iodine Therapy for Thyroid Carcinomas Exhibiting Nodal Metastases and Extrathyroidal Extension May Lead to Early Disease Recurrence.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0136.
    PubMed     Text format     Abstract available


  71. CABANILLAS M, Ferrarotto R, Garden A, Ahmed S, et al
    Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2018.0060.
    PubMed     Text format     Abstract available


  72. MOSS W, Finegersh A, Pang J, Califano JA, et al
    Needle biopsy of routine thyroid nodules should be performed using a capillary action technique with 24-27 gauge needles: a systematic review and meta-analysis.
    Thyroid. 2018 May 10. doi: 10.1089/thy.2017.0643.
    PubMed     Text format     Abstract available



  73. Correction to: Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study, by Kim M, Kim TH, Shin DY, Lim DJ, Kim EY, Kim WB, Chung JH, Shong YK, Kim BH, an
    Thyroid. 2018;28:686.
    PubMed     Text format    


    April 2018
  74. VERBURG F, Maeder U, Giovanella L, Luster M, et al
    Low or undetectable basal thyroglobulin levels obviate the need for neck ultrasound in differentiated thyroid cancer patients after total thyroidectomy and I-131 ablation.
    Thyroid. 2018 Apr 18. doi: 10.1089/thy.2017.0352.
    PubMed     Text format     Abstract available


  75. NABHAN F, Porter K, Lupo M, Randolph GW, et al
    Heterogeneity in PPV of RAS Mutations in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2018 Apr 18. doi: 10.1089/thy.2017.0635.
    PubMed     Text format     Abstract available


  76. DAVIES L, Sugino K, Sugitani I, Tomoda C, et al
    Response to Magner JA: "High Thyroid Cancer Mortality Rate in Japan: A Result of Non-aggressive Treatment Strategy, or Just an Aging Population?"
    Thyroid. 2018 Apr 12. doi: 10.1089/thy.2018.0203.
    PubMed     Text format     Abstract available


  77. BUJ R, Mallona I, Diez-Villanueva A, Zafon C, et al
    Kallikreins stepwise scoring reveals three subtypes of papillary thyroid cancer with prognostic applications.
    Thyroid. 2018 Apr 11. doi: 10.1089/thy.2017.0501.
    PubMed     Text format     Abstract available


  78. HUANG P, Mao LF, Zhang ZP, Lv WW, et al
    Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Thyroid. 2018 Apr 10. doi: 10.1089/thy.2017.0401.
    PubMed     Text format     Abstract available


  79. SINGH-OSPINA N, Castaneda-Guarderas A, Hamidi O, Ponce OJ, et al
    Weight changes after thyroid surgery for patients with benign thyroid nodules and thyroid cancer: population based study and systematic review and meta-analysis.
    Thyroid. 2018 Apr 10. doi: 10.1089/thy.2017.0216.
    PubMed     Text format     Abstract available


  80. MAGNER JA
    High Thyroid Cancer Mortality Rate in Japan: A Result of Nonaggressive Treatment Strategy, or Just an Aging Population?
    Thyroid. 2018 Apr 9. doi: 10.1089/thy.2018.0121.
    PubMed     Text format    


  81. KIM M, Jeon MJ, Oh HS, Park S, et al
    Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.
    Thyroid. 2018 Apr 5. doi: 10.1089/thy.2017.0473.
    PubMed     Text format     Abstract available


  82. WANG Z, Vyas CM, Van Benschoten O, Nehs MA, et al
    Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients >/=70 Years Old.
    Thyroid. 2018 Apr 2. doi: 10.1089/thy.2017.0655.
    PubMed     Text format     Abstract available


  83. ITO Y, Miyauchi A, Kudo T, Oda H, et al
    Trends in the Implementation of Active Surveillance for Low-Risk Papillary Thyroid Microcarcinomas at Kuma Hospital: Gradual Increase and Heterogeneity in the Acceptance of This New Management Option.
    Thyroid. 2018 Apr 2. doi: 10.1089/thy.2017.0448.
    PubMed     Text format     Abstract available


    March 2018
  84. LIM JXY, Nga ME, Chan DKH, Tan WB, et al
    Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.
    Thyroid. 2018 Mar 29. doi: 10.1089/thy.2017.0274.
    PubMed     Text format     Abstract available


  85. BONGIOVANNI M, Papadakis GE, Rouiller N, Marino L, et al
    The Bethesda System for Reporting Thyroid Cytopathology explained for practitioners: Frequently Asked Questions.
    Thyroid. 2018 Mar 28. doi: 10.1089/thy.2017.0685.
    PubMed     Text format     Abstract available


  86. ROSARIO PW
    Re: "A Follow-Up Strategy for Patients with Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma" by Jeon et al. (Thyroid 2018;28:187-192).
    Thyroid. 2018 Mar 27. doi: 10.1089/thy.2017.0644.
    PubMed     Text format    


  87. LEUNG AM, Lubin JH, Schneider AB
    Response to Cuttler et al. Re: ''Low-Dose Childhood Radiation Effectsto the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years After Exposure''.
    Thyroid. 2018 Mar 26. doi: 10.1089/thy.2018.0185.
    PubMed     Text format     Abstract available


  88. MILLER JE, Al-Attar NC, Brown OH, Shaughness GG, et al
    Location and causation of residual lymph node metastasis after surgical treatment of regionally advanced differentiated thyroid cancer.
    Thyroid. 2018 Mar 21. doi: 10.1089/thy.2017.0434.
    PubMed     Text format     Abstract available


    February 2018
  89. DOBNIG H, Amrein K
    Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single center study.
    Thyroid. 2018 Feb 28. doi: 10.1089/thy.2017.0547.
    PubMed     Text format     Abstract available


  90. YAISH I, Azem F, Gutfeld O, Silman Z, et al
    A Single Radioactive Iodine Treatment has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
    Thyroid. 2018 Feb 21. doi: 10.1089/thy.2017.0442.
    PubMed     Text format     Abstract available


  91. AGHAJANI M, Graham S, McCafferty C, Shaheed CA, et al
    The clinicopathological and prognostic significance of programmed cell death ligand 1 (PD-L1) expression in patients with non-medullary thyroid cancer: a systematic review and meta-analysis.
    Thyroid. 2018 Feb 17. doi: 10.1089/thy.2017.0441.
    PubMed     Text format     Abstract available


  92. LEI J, Zhong J, Li Z, Wei T, et al
    A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0422.
    PubMed     Text format     Abstract available


  93. KIM M, Jeon M, Oh HS, Park S, et al
    <i>BRAF</i> and <i>RAS</i> mutational status in non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0382.
    PubMed     Text format     Abstract available


  94. NASH SH, Lanier AP, Southworth MB
    Occurrence of endocrine and thyroid cancers among Alaska Native people, 1969-2013.
    Thyroid. 2018 Feb 14. doi: 10.1089/thy.2017.0408.
    PubMed     Text format     Abstract available


  95. HIRSCH D, Twito O, Levy S, Bachar G, et al
    Temporal Trends in the Presentation, Treatment, and Outcome of Medullary Thyroid Carcinoma - An Israeli Multicenter Study.
    Thyroid. 2018 Feb 5. doi: 10.1089/thy.2017.0371.
    PubMed     Text format     Abstract available


    January 2018
  96. LUBITZ CC, Zhan T, Gunda V, Amin S, et al
    Circulating BRAFV600E levels correlate with treatment in patients with thyroid carcinoma.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0322.
    PubMed     Text format     Abstract available


  97. JAHANBANI I, Al-Abdallah A, Ali R, Al-Brahim N, et al
    Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Thyroid. 2018 Jan 29. doi: 10.1089/thy.2017.0127.
    PubMed     Text format     Abstract available


  98. NGUYEN XV, Roy Choudhury K, Tessler FN, Hoang JK, et al
    Effect of tumor size on risk of metastatic disease and survival for thyroid cancer: Implications for biopsy guidelines.
    Thyroid. 2018 Jan 26. doi: 10.1089/thy.2017.0526.
    PubMed     Text format     Abstract available


  99. KIM M, Kim TH, Shin DY, Lim DJ, et al
    Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0356.
    PubMed     Text format     Abstract available


  100. OH HS, Kwon H, Song E, Jeon M, et al
    Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Thyroid. 2018 Jan 19. doi: 10.1089/thy.2017.0514.
    PubMed     Text format     Abstract available


  101. KIM MJ, Won JK, Jung KC, Kim JH, et al
    Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma.
    Thyroid. 2018 Jan 17. doi: 10.1089/thy.2016.0671.
    PubMed     Text format     Abstract available


  102. CARVALHO M, Rosario PW, Mourao GF, Oliveira LFF, et al
    Clinical impact of detectable antithyroglobulin antibodies below the reference limit (borderline) in patients with papillary thyroid carcinoma with negative serum thyroglobulin and neck ultrasonography after ablation: a prospective study.
    Thyroid. 2018 Jan 12. doi: 10.1089/thy.2017.0350.
    PubMed     Text format     Abstract available


    December 2017
  103. YAKUSHINA VD, Lerner LV, Lavrov AV
    Gene fusions in thyroid cancer.
    Thyroid. 2017 Dec 27. doi: 10.1089/thy.2017.0318.
    PubMed     Text format     Abstract available


  104. KIM KH, Gu MO, Jung J, Hahm JR, et al
    Efficacy of a home-based exercise program after thyroidectomy for thyroid cancer patients.
    Thyroid. 2017 Dec 19. doi: 10.1089/thy.2017.0277.
    PubMed     Text format     Abstract available


  105. STEINSCHNEIDER M, Muallem Kalmovich L, Koren S, Or K, et al
    Reassessment of Differentiated Thyroid Cancer Patients Using the 8th TNM classification System: a comparative study.
    Thyroid. 2017 Dec 19. doi: 10.1089/thy.2017.0265.
    PubMed     Text format     Abstract available


    November 2017
  106. TOMODA C, Sugino K, Tanaka T, Ogimi Y, et al
    Globus symptoms in patients undergoing thyroidectomy: Relationships with psychogenic factors, thyroid disease, and surgical procedure.
    Thyroid. 2017 Nov 28. doi: 10.1089/thy.2017.0524.
    PubMed     Text format     Abstract available


  107. JEON M, Kim M, Park S, Oh HS, et al
    A follow-up strategy for patients with excellent response to initial therapy for differentiated thyroid carcinoma : less is better.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0130.
    PubMed     Text format     Abstract available


  108. WATUTANTRIGE-FERNANDO S, Vianello F, Barollo S, Bertazza L, et al
    The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0248.
    PubMed     Text format     Abstract available


  109. JEON M, Kim YN, Sung TY, Hong SJ, et al
    Practical initial risk stratification based on lymph node metastases in pediatric and adolescent differentiated thyroid cancer.
    Thyroid. 2017 Nov 27. doi: 10.1089/thy.2017.0214.
    PubMed     Text format     Abstract available


  110. IYER P, Dadu R, Ferrarotto R, Busaidy N, et al
    Real world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma.
    Thyroid. 2017 Nov 22. doi: 10.1089/thy.2017.0285.
    PubMed     Text format     Abstract available


  111. CHEN AJ, Livhits MJ, Du L, Wu JX, et al
    Recent Pregnancy is Not Associated with High-Risk Pathological Features of Well-Differentiated Thyroid Cancer.
    Thyroid. 2017 Nov 21. doi: 10.1089/thy.2017.0496.
    PubMed     Text format     Abstract available


  112. HAN MA, Kim JH
    Diagnostic x-ray exposure and thyroid cancer risk: systematic review and meta-analysis.
    Thyroid. 2017 Nov 21. doi: 10.1089/thy.2017.0159.
    PubMed     Text format     Abstract available


  113. VALDERRABANO P, Khazai L, Thompson ZJ, Sharpe SC, et al
    Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules. A systematic review and meta-analysis.
    Thyroid. 2017 Nov 21. doi: 10.1089/thy.2017.0419.
    PubMed     Text format     Abstract available


  114. KLEIN HESSELINK MS, Bocca G, Hummel YM, Brouwers AH, et al
    Diastolic dysfunction is common in survivors of pediatric differentiated thyroid carcinoma.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0383.
    PubMed     Text format     Abstract available


  115. GOMES-LIMA CJ, Wu D, Kharazi PH, Khorjekar G, et al
    Selected Radiation Safety Aspects including Transportation and Lodging after Outpatient <sup>131</sup>I Therapy for Differentiated Thyroid Cancer.
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0124.
    PubMed     Text format     Abstract available


  116. CUTTLER J, Mortazavi S, Welsh J, Doss M, et al
    Comments on "Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure".
    Thyroid. 2017 Nov 13. doi: 10.1089/thy.2017.0377.
    PubMed     Text format     Abstract available


  117. NAM SH, Roh JL, Gong G, Cho KJ, et al
    Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
    Thyroid. 2017 Nov 8. doi: 10.1089/thy.2017.0334.
    PubMed     Text format     Abstract available


  118. KUO EJ, Thi WJ, Zheng F, Zanocco K, et al
    Individualizing surgery in papillary thyroid carcinoma based on a detailed sonographic assessment of extrathyroidal extension.
    Thyroid. 2017 Nov 7. doi: 10.1089/thy.2017.0457.
    PubMed     Text format     Abstract available


  119. HA SM, Ahn HS, Baek JH, Ahn HY, et al
    Validation of Three Scoring Risk Stratification Models for Thyroid Nodules.
    Thyroid. 2017 Nov 6. doi: 10.1089/thy.2017.0363.
    PubMed     Text format     Abstract available


  120. MOSTOUFI-MOAB S, Labourier E, Sullivan L, LiVolsi VA, et al
    Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.
    Thyroid. 2017 Nov 6. doi: 10.1089/thy.2017.0059.
    PubMed     Text format     Abstract available


  121. VALENCIAGA A, Grubbs EG, Porter K, Wakely PE Jr, et al
    REDUCED RETINOBLASTOMA PROTEIN EXPRESSION IS ASSOCIATED WITH DECREASED PATIENT SURVIVAL IN MEDULLARY THYROID CANCER.
    Thyroid. 2017 Nov 4. doi: 10.1089/thy.2017.0113.
    PubMed     Text format     Abstract available


  122. CIBAS ES, Ali SZ
    The 2017 Bethesda System for Reporting Thyroid Cytopathology.
    Thyroid. 2017;27:1341-1346.
    PubMed     Text format     Abstract available


    October 2017
  123. SCHMOHL KA, Dolp P, Schug C, Knoop K, et al
    Reintroducing the sodium iodide symporter (NIS) to anaplastic thyroid carcinoma.
    Thyroid. 2017 Oct 15. doi: 10.1089/thy.2017.0290.
    PubMed     Text format     Abstract available


  124. LAMARTINA L, Durante C, Lucisano G, Grani G, et al
    Are evidence-based guidelines reflected in clinical practice? An analysis of prospectively collected data of the Italian Thyroid Cancer Observatory (ITCO#1).
    Thyroid. 2017 Oct 12. doi: 10.1089/thy.2017.0299.
    PubMed     Text format     Abstract available


  125. HERNANDEZ-PRERA J, Machado R, Asa SL, Baloch ZW, et al
    Pathologic reporting of Tall Cell Variant of Papillary Thyroid Cancer: Have we reached a consensus?
    Thyroid. 2017 Oct 12. doi: 10.1089/thy.2017.0280.
    PubMed     Text format     Abstract available


  126. BARDET S, Ciappuccini R, Pellot-Barakat C, Monpeyssen H, et al
    Shear wave elastography in thyroid nodules with indeterminate cytology: Results of a prospective bicentric study.
    Thyroid. 2017 Oct 6. doi: 10.1089/thy.2017.0293.
    PubMed     Text format     Abstract available


  127. AYUBI E, Sullman MJM, Safiri S
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy: Comment on Data Sparsity.
    Thyroid. 2017 Oct 1. doi: 10.1089/thy.2017.0303.
    PubMed     Text format     Abstract available


    September 2017
  128. YAMASHITA S
    Lessons from Fukushima: Latest Findings of Thyroid Cancer after the Fukushima Nuclear Power Plant Accident.
    Thyroid. 2017 Sep 27. doi: 10.1089/thy.2017.0283.
    PubMed     Text format     Abstract available


  129. HA EJ, Baek JH, Na DG
    Risk Stratification of Thyroid Nodules on Ultrasonography: Current Status and Perspectives.
    Thyroid. 2017 Sep 25. doi: 10.1089/thy.2016.0654.
    PubMed     Text format     Abstract available


  130. CANO JM, Galan R, Lopez R
    Recurrent Metastatic Medullary Thyroid Carcinoma: A Case of Sustained Response to Prolonged Treatment with Somatostatin Analogues.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


  131. LEE SI, Kim DK, Seo EJ, Choi EJ, et al
    Role of Kruppel-like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Thyroid. 2017.
    PubMed     Text format     Abstract available


  132. YAPA S, Mulla O, Green V, England J, et al
    The Role of Chemokines in Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2016.0660.
    PubMed     Text format     Abstract available


  133. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    <i>ESR2</i> gene and Medullary Thyroid Carcinoma.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0171.
    PubMed     Text format     Abstract available


  134. PONTIUS LN, Oyekunle TO, Thomas S, Stang M, et al
    Projecting Survival in Papillary Thyroid Cancer: A Comparison of the 7th and 8th Editions of the AJCC/UICC Staging Systems in Two Contemporary National Patient Cohorts.
    Thyroid. 2017 Sep 11. doi: 10.1089/thy.2017.0306.
    PubMed     Text format     Abstract available


  135. HEDMAN C, Strang P, Djarv T, Widberg I, et al
    Anxiety and fear of recurrence despite a good prognosis: an interview study with differentiated thyroid cancer patients.
    Thyroid. 2017 Sep 6. doi: 10.1089/thy.2017.0346.
    PubMed     Text format     Abstract available


    August 2017
  136. SAHLI ZT, Umbricht CB, Schneider EB, Zeiger MA Md, et al
    Thyroid Nodule Diagnostic Markers in the Face of the New Diagnosis, NIFT-P: Time for a Reset?
    Thyroid. 2017 Aug 31. doi: 10.1089/thy.2017.0238.
    PubMed     Text format     Abstract available


  137. HALL S, Irish JC, Groome PA, Griffiths R, et al
    Do lower risk thyroid cancer patients who live in regions with more aggressive treatments have better outcomes?
    Thyroid. 2017 Aug 29. doi: 10.1089/thy.2017.0103.
    PubMed     Text format     Abstract available


  138. SUNG TY, Cho JW, Lee YM, Lee YH, et al
    Dynamic Risk Stratification in Stage I Papillary Thyroid Cancer Patients Younger than 45 Years.
    Thyroid. 2017 Aug 28. doi: 10.1089/thy.2017.0199.
    PubMed     Text format     Abstract available


  139. CHINN SB, Zafereo M, Waguespack SG, Edeiken BS, et al
    Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0203.
    PubMed     Text format     Abstract available


  140. VALDERRABANO P, Khazai L, Thompson ZJ, Leon ME, et al
    Cancer risk stratification of indeterminate thyroid nodules: A cytological approach.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0221.
    PubMed     Text format     Abstract available


  141. GRANI G, Bruno R, Lucisano G, Costante G, et al
    Temporal changes in thyroid nodule volume: lack of effect on paranodular thyroid tissue volume.
    Thyroid. 2017 Aug 15. doi: 10.1089/thy.2017.0201.
    PubMed     Text format     Abstract available


  142. WHITE PS, Pudusseri A, Lee SL, Eton O, et al
    Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports.
    Thyroid. 2017 Aug 12. doi: 10.1089/thy.2017.0106.
    PubMed     Text format     Abstract available


  143. RUHLMANN M, Ruhlmann J, Gorges R, Herrmann K, et al
    18F-FDG PET/CT may exclude malignancy in sonographically suspicious and scintigraphically hypofunctional thyroid nodules and reduce unnecessary thyroid surgeries.
    Thyroid. 2017 Aug 10. doi: 10.1089/thy.2017.0026.
    PubMed     Text format     Abstract available


  144. ROBENSHTOK E, Nachalon Y, Benbassat C, Hirsch D, et al
    Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0040.
    PubMed     Text format     Abstract available


  145. SUH CH, Choi YJ, Lee JJ, Shim WH, et al
    Comparison of Core-Needle Biopsy and Fine-Needle Aspiration for Evaluating Thyroid Incidentalomas Detected by 18F-FDG PET/CT: A Propensity Score Analysis.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0192.
    PubMed     Text format     Abstract available


  146. HA SM, Baek JH, Kim JK
    Detection of malignancy among suspicious thyroid nodules less than 1 cm on ultrasound with various thyroid image reporting and data systems.
    Thyroid. 2017 Aug 9. doi: 10.1089/thy.2017.0034.
    PubMed     Text format     Abstract available


    July 2017
  147. OH HS, Park S, Kim M, Kwon H, et al
    Young age and male sex can predict for a large-volume central neck lymph node metastasis in clinical N0 papillary thyroid microcarcinoma.
    Thyroid. 2017 Jul 25. doi: 10.1089/thy.2017.0250.
    PubMed     Text format     Abstract available


  148. ALHASHEMI A, Jones J, Goldstein DP, Santa Mina D, et al
    An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients.
    Thyroid. 2017 Jul 16. doi: 10.1089/thy.2016.0541.
    PubMed     Text format     Abstract available


  149. HAHN SY, Shin JH, Oh YL, Kim TH, et al
    Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2016.0677.
    PubMed     Text format     Abstract available


  150. PARK S, Kim WG, Han M, Jeon M, et al
    Thyroid-Stimulating Hormone Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
    Thyroid. 2017 Jul 12. doi: 10.1089/thy.2017.0177.
    PubMed     Text format     Abstract available


    June 2017
  151. KIYOTA N, Robinson B, Shah MH Md, Hoff AO, et al
    Defining Radioiodine-refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-refractory Criteria in the SELECT Trial.
    Thyroid. 2017 Jun 30. doi: 10.1089/thy.2016.0549.
    PubMed     Text format     Abstract available


  152. TANG AL, Falciglia M, Yang H, Mark JR, et al
    Validation of ATA Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine Needle Aspiration.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0555.
    PubMed     Text format     Abstract available


  153. KLUBO-GWIEZDZINSKA J, Yang LA, Merkel R, Patel D, et al
    Results of screening in familial nonmedullary thyroid cancer.
    Thyroid. 2017 Jun 28. doi: 10.1089/thy.2016.0668.
    PubMed     Text format     Abstract available


  154. ITO Y, Onoda N, Ito KI, Sugitani I, et al
    Sorafenib in Japanese Patients With Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2016.0621.
    PubMed     Text format     Abstract available


  155. KIM M, Kim WG, Oh HS, Park S, et al
    Comparison of the 7th and 8th Editions of the AJCC/UICC TNM Staging System for Differentiated Thyroid Cancer.
    Thyroid. 2017 Jun 21. doi: 10.1089/thy.2017.0050.
    PubMed     Text format     Abstract available


  156. MIYAUCHI A, Ito Y, Oda H
    Insights into the management of papillary microcarcinoma of the thyroid.
    Thyroid. 2017 Jun 19. doi: 10.1089/thy.2017.0227.
    PubMed     Text format     Abstract available


  157. SILVA-VIEIRA M, Carrilho-Vaz S, Esteves S, C Ferreira T, et al
    Second Primary Cancer in Patients with Differentiated Thyroid Cancer: Does Radioiodine Play a Role?
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0655.
    PubMed     Text format     Abstract available


  158. YABUTA T, Matsuse M, Hirokawa M, Yamashita S, et al
    TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance.
    Thyroid. 2017 Jun 14. doi: 10.1089/thy.2016.0645.
    PubMed     Text format     Abstract available


  159. PILLI T, Cantara S, Marzocchi C, Cardinale S, et al
    Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
    Thyroid. 2017 Jun 12. doi: 10.1089/thy.2017.0035.
    PubMed     Text format     Abstract available


    May 2017
  160. GONZALEZ HE, Martinez JR, Vargas S, Solar A, et al
    A 10-gene classifier for indeterminate thyroid nodules: Development and multicenter accuracy study.
    Thyroid. 2017 May 18. doi: 10.1089/thy.2017.0067.
    PubMed     Text format     Abstract available


  161. POLE JD, Zuk AM, Wasserman JD
    Diagnostic and Treatment Patterns among Children, Adolescents and Young Adults with Thyroid Cancer in Ontario: 1992-2010.
    Thyroid. 2017 May 17. doi: 10.1089/thy.2016.0629.
    PubMed     Text format     Abstract available


  162. RANDLE RW, Bushman NM, Orne J, Balentine CJ, et al
    PAPILLARY THYROID CANCER: THE GOOD AND BAD OF THE "GOOD CANCER".
    Thyroid. 2017 May 16. doi: 10.1089/thy.2016.0632.
    PubMed     Text format     Abstract available


  163. HAMAOKA Y
    Comment on "Comprehensive Survey Results of Childhood Thyroid Ultrasound Examinations in Fukushima in the First Four Years after the Fukushima Daiichi Nuclear Power Plant Accident".
    Thyroid. 2017 May 15. doi: 10.1089/thy.2016.0464.
    PubMed     Text format     Abstract available


  164. WILSON L, Huang W, Chen L, Ting J, et al
    Cost-Effectiveness of Lenvatinib, Sorafenib, and Placebo in the Treatment of Radioiodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2017 May 9. doi: 10.1089/thy.2016.0572.
    PubMed     Text format     Abstract available


  165. HEDMAN C, Djarv T, Strang P, Lundgren CI, et al
    The effect of thyroid-related symptoms on long-term quality of life in patients with differentiated thyroid carcinoma - a population-based study in Sweden.
    Thyroid. 2017 May 5. doi: 10.1089/thy.2016.0604.
    PubMed     Text format     Abstract available


  166. INIGUEZ ARIZA NM, Ryder M, Hilger CR, Bible KC, et al
    Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2017 May 4. doi: 10.1089/thy.2016.0627.
    PubMed     Text format     Abstract available


  167. KIM M, Kim WG, Park S, Kwon H, et al
    Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma.
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0676.
    PubMed     Text format     Abstract available


  168. HONG MJ, Na DG, Baek JH, Sung JY, et al
    Cytology-Ultrasonography (CU) Risk Stratification Scoring System Based on Fine-needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System (K-TIRADS).
    Thyroid. 2017 May 2. doi: 10.1089/thy.2016.0603.
    PubMed     Text format     Abstract available


  169. TUTTLE RM MD, Haugen BR Md, Perrier N
    The Updated AJCC/TNM Staging System for Differentiated and Anaplastic Thyroid Cancer (8th edition): What changed and why?
    Thyroid. 2017 May 2. doi: 10.1089/thy.2017.0102.
    PubMed     Text format     Abstract available


  170. CHUNG SR, Baek JH, Park HS, Choi YJ, et al
    Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Thyroid. 2017;27:707-713.
    PubMed     Text format     Abstract available


    April 2017
  171. RUBIO GA, Koru-Sengul T, Vaghaiwalla TM, Parikh PP, et al
    Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
    Thyroid. 2017 Apr 29. doi: 10.1089/thy.2016.0500.
    PubMed     Text format     Abstract available


  172. OH HS, Kim WG, Park S, Kim M, et al
    Serial neck ultrasonographic evaluation of changes in papillary thyroid carcinoma during pregnancy.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0618.
    PubMed     Text format     Abstract available


  173. KIM H, Kim TH, Choe JH, Kim JH, et al
    Patterns of initial recurrence in completely resected papillary thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0648.
    PubMed     Text format     Abstract available


  174. YANG Z, Flores J, Katz S, Nathan CA, et al
    Comparison of survival outcomes following post-surgical radioactive iodine versus external beam radiation in stage IV differentiated thyroid carcinoma.
    Thyroid. 2017 Apr 27. doi: 10.1089/thy.2016.0650.
    PubMed     Text format     Abstract available


  175. MA C, Feng F, Wang S, Fu H, et al
    Chinese data of efficacy of low- and high-dose of iodine-131 for the ablation of thyroid remnant.
    Thyroid. 2017 Apr 12. doi: 10.1089/thy.2015.0658.
    PubMed     Text format     Abstract available


  176. PAULSON VA, Shivdasani P, Angell TE, Cibas ES, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Thyroid. 2017;27:506-511.
    PubMed     Text format     Abstract available


  177. MUJAMMAMI M, Tamilia M
    Response to Tulchinsky and Avram re: "Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine".
    Thyroid. 2017;27:592.
    PubMed     Text format    


    March 2017
  178. IYAMA K, Matsuse M, Mitsutake N, Rogounovitch T, et al
    Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET in Thyroid Cancers of Young Patients in Fukushima.
    Thyroid. 2017 Mar 29. doi: 10.1089/thy.2016.0673.
    PubMed     Text format     Abstract available


  179. BONHOMME B, Godbert Y, Perot G, Alghuzlan A, et al
    Molecular pathology of anaplastic thyroid carcinomas: a retrospective study of 144 cases.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0254.
    PubMed     Text format     Abstract available


  180. TAVARELLI M, Sarfati J, Chereau N, Tissier F, et al
    Heterogeneous prognoses for pT3 papillary thyroid carcinomas and impact of delayed risk stratification.
    Thyroid. 2017 Mar 28. doi: 10.1089/thy.2016.0512.
    PubMed     Text format     Abstract available


  181. IZKHAKOV E, Barchana M, Liphshiz I, Silverman B, et al
    Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel.
    Thyroid. 2017 Mar 24. doi: 10.1089/thy.2016.0481.
    PubMed     Text format     Abstract available


  182. LANG BH, Woo YC, Chiu KW
    Single-Session High-Intensity Focused Ultrasound Treatment in Large-Sized Benign Thyroid Nodules.
    Thyroid. 2017 Mar 22. doi: 10.1089/thy.2016.0664.
    PubMed     Text format     Abstract available


  183. NICKEL B, Brito JP, Barratt A, Jordan S, et al
    Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
    Thyroid. 2017 Mar 21. doi: 10.1089/thy.2016.0483.
    PubMed     Text format     Abstract available


  184. SHAH SA, Adam MA, Thomas S, Scheri RP, et al
    Racial Disparities In Differentiated Thyroid Cancer: Have We Bridged The Gap?
    Thyroid. 2017 Mar 15. doi: 10.1089/thy.2016.0626.
    PubMed     Text format     Abstract available


  185. ZANELLA AB, Scheffel RS, Pasa M, Dora JM, et al
    The Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Thyroid. 2017 Mar 14. doi: 10.1089/thy.2016.0559.
    PubMed     Text format     Abstract available


    February 2017
  186. MOON S, Song YS, Kim YA, Lim JA, et al
    Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2017 Feb 9. doi: 10.1089/thy.2016.0350.
    PubMed     Text format     Abstract available


    January 2017
  187. XU B, Tallini G, Scognamiglio T, Roman BR, et al
    Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
    Thyroid. 2017 Jan 30. doi: 10.1089/thy.2016.0649.
    PubMed     Text format     Abstract available


  188. MURATA T, Iwadate M, Takizawa Y, Miyakoshi M, et al
    An adult mouse thyroid side population cell line that exhibits enriched epithelial-to-mesenchymal transition.
    Thyroid. 2017 Jan 27. doi: 10.1089/thy.2016.0130.
    PubMed     Text format     Abstract available


  189. GRIFFIN A, Brito JP, Bahl M, Hoang JK, et al
    Applying criteria of active surveillance to low-risk thyroid papillary cancer over a decade: How many surgeries and complications can be avoided?
    Thyroid. 2017 Jan 26. doi: 10.1089/thy.2016.0568.
    PubMed     Text format     Abstract available


  190. HAUGEN BR MD, Sawka AM, Alexander EK, Bible KC, et al
    The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP.
    Thyroid. 2017 Jan 23. doi: 10.1089/thy.2016.0628.
    PubMed     Text format     Abstract available


  191. CHOI YJ, Baek JH, Park HS, Shim WH, et al
    A computer-aided diagnosis system using artificial intelligence for the diagnosis and characterization of thyroid nodules on ultrasound: initial clinical assessment.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0372.
    PubMed     Text format     Abstract available


  192. ESZLINGER M, Bohme K, Ullmann M, Gorke F, et al
    Evaluation of a two-year routine application of molecular testing of thyroid fine needle aspirations (FNA) using a 7-gene-panel in a primary referral setting in Germany.
    Thyroid. 2017 Jan 10. doi: 10.1089/thy.2016.0445.
    PubMed     Text format     Abstract available


  193. ALEXANDER EK, Pearce EN, Brent GA, Brown RS, et al
    2016 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum.
    Thyroid. 2017 Jan 6. doi: 10.1089/thy.2016.0457.
    PubMed     Text format     Abstract available


  194. ITO M, Miyauchi A, Fujiwara M, Yoshioka W, et al
    Biochemical markers reflecting thyroid function in athyreotic patients on levothyroxine monotherapy.
    Thyroid. 2017 Jan 5. doi: 10.1089/thy.2016.0426.
    PubMed     Text format     Abstract available


  195. CAVALLO A, Johnson DN, White MG, Siddiqui S, et al
    Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size.
    Thyroid. 2017 Jan 4. doi: 10.1089/thy.2016.0336.
    PubMed     Text format     Abstract available


  196. VAN DER WARDT RA, Persoon AC, Klein Hesselink EN, Links TP, et al
    Long-term follow-up for differentiated thyroid carcinoma patients - a reconsideration.
    Thyroid. 2017 Jan 3. doi: 10.1089/thy.2016.0314.
    PubMed     Text format     Abstract available


  197. AZMAT U, Porter K, Senter L, Ringel MD, et al
    Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Has a Low Sensitivity for Detecting Structural Disease in Patients with Antithyroglobulin Antibodies.
    Thyroid. 2017;27:74-80.
    PubMed     Text format     Abstract available


    December 2016
  198. SHEN FC, Hsieh CJ, Huang IC, Chang YH, et al
    Dynamic risk estimates of outcome in Chinese patients with well-differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation.
    Thyroid. 2016 Dec 22. doi: 10.1089/thy.2016.0479.
    PubMed     Text format     Abstract available


  199. HAYMART MR, Pearce EN
    How Much Should Thyroid Cancer Impact Plans for Pregnancy?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    November 2016
  200. PARK S, Kim WG, Song E, Oh HS, et al
    Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated without Radioactive Iodine Remnant Ablation Therapy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  201. SHAHA MA, Wang LY, Migliacci JC, Palmer FL, et al
    Previous external beam radiation treatment exposure does not confer worse outcome for patients with differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  202. RAKHLIN L, Fish S, Tuttle RM Md
    Response to therapy status is an excellent predictor of pregnancy-associated structural disease progression in patients previously treated for differentiated thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  203. JI Q, Shi R, Qu N, Luo T, et al
    Programmed death-ligand 1 expression in papillary thyroid cancer and its correlation with clinicopathological factors and recurrence.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  204. ALZAHRANI AS, Murugan AK, Qasem E, Alswailem M, et al
    Single Point Mutations in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  205. RAGO T, Scutari M, Loiacono V, Santini F, et al
    Low elasticity of thyroid nodules at ultrasound elastography is correlated with malignancy, degree of fibrosis and high expression of galectin-3 and fibronectin-1.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    October 2016
  206. CASTELBLANCO E, Zafon C, Maravall J, Gallel P, et al
    APLP2, RRM2 and PRC1: new putative markers for the differential diagnosis of thyroid follicular lesions.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  207. RABINOWITS G, Barletta J, Sholl LM, Reche E, et al
    Successful Management of a Patient with Malignant Thyroid Teratoma.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  208. JEONG HS, Choi EK, Song IU, Chung YA, et al
    Differences in brain glucose metabolism during preparation for I-131 ablation in thyroid cancer patients: Thyroid hormone withdrawal versus recombinant human thyrotropin.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  209. MERTEN MM, Castro MR, Zhang J, Durski JM, et al
    Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography (PET/CT) in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  210. WANG Q, Yang H, Wu L, Yao J, et al
    Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathological Characteristics and BRAF-mutation in Papillary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  211. BHALLA S, Monga D, Soni T, Gaurang A, et al
    Competency Education of Primary Care Physicians in Management of Thyroid Disorders: Implementation Experiences from a Pan India Certificate Course.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  212. ROSSING RM, Jentzen W, Nagarajah J, Bockisch A, et al
    Serum thyroglobulin doubling time in progressive thyroid cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  213. LEE SG, Lee WK, Lee HS, Moon J, et al
    Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  214. GAVRILA A, Hasselgren PO, Glasgow A, Doyle AN, et al
    Variable Cold-induced Brown Adipose Tissue Response to Thyroid Hormone Status.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  215. NAJAFIAN A, Noureldine SI, Azar F, Atallah C, et al
    RAS Mutations, RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions? Implications Thereof and, A Systematic Review.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  216. TULCHINSKY M, Avram A
    Long-Term Outcomes of Patients with Papillary Thyroid Cancer Undergoing Remnant Ablation with 30 Millicurie Radioiodine: Patient Cohort Definition Makes No Sense.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    September 2016
  217. AHN HS, Kim HJ, Kim KH, Lee YS, et al
    Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  218. REN Y, Lence-Anta JJ, Pereda C, Chappa M, et al
    Foxe1 Polymorphism Interacts with Dietary Iodine Intake in Differentiated Thyroid Cancer Risk in the Cuban Population.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  219. SINGER S, Husson O, Tomaszewska IM, Locati L, et al
    Quality of life priorities in patients with thyroid cancer - a multi-national EORTC phase I study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  220. YOUNGWIRTH L, Abdelgadir Adam M, Scheri R, Roman S, et al
    Extrathyroidal Extension is Associated with Compromised Survival in Patients with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    August 2016
  221. WILTSHIRE JJ, Drake TM, Uttley L, Balasubramanian SP, et al
    Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  222. IPPOLITO S, Ippolito R, Peirce C, Esposito R, et al
    Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  223. ESPINOSA DE YCAZA AE, Lowe KM, Dean DS, Castro MR, et al
    Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  224. PIRES B, Alves-Junior PA, Bordallo MA, Bulzico DA, et al
    Prognostic factors for early and long-term remission in pediatric differentiated thyroid cancer: the role of gender, age, clinical presentation and the newly proposed American Thyroid Association risk stratification system.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  225. ONODA N, Sugino K, Higashiyama T, Kammori M, et al
    The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients: A nationwide prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  226. NIXON IJ, Simo R, Newbold K, Rinaldo A, et al
    Management of Invasive Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    July 2016
  227. CUI K, Zhang M, Fu C, Ma X, et al
    Comment on "Partially Cystic Thyroid Nodules on Ultrasound: Probability of Malignancy and Sonographic Differentiation".
    Thyroid. 2016.
    PubMed     Text format    


  228. STRICKLAND KC, Vivero M, Jo VY, Lowe AC, et al
    Pre-operative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): A Prospective Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  229. ZHANG M, Luo Y, Zhang Y, Tang J, et al
    Efficacy and safety of ultrasound guided radiofrequency ablation for treating low risk papillary thyroid microcarcinoma: a prospective study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  230. RATZON NZ, Uziely B, de Boer AG, Rottenberg Y, et al
    Unemployment risk and decreased income 2 and 4 years after thyroid cancer diagnosis: a population based study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    June 2016
  231. HYUN YG, Alhashemi A, Fazelzad R, Goldberg AS, et al
    A Systematic Review of Unmet Information and Psychosocial Support Needs of Adults Diagnosed with Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  232. MALANDRINO P, Russo M, Regalbuto C, Pellegriti G, et al
    The Outcome Of The Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  233. BERNSTEIN MB, Chang EL, Amini B, Pan H, et al
    SPINE STEREOTACTIC RADIOSURGERY FOR PATIENTS WITH METASTATIC THYROID CANCER - Secondary analysis of Phase I/II trials.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  234. VALDERRABANO P, Montilla Soler J, Mifsud MJ, Leon ME, et al
    Hypermetabolism on 18F-FDG PET scan does not influence the interpretation of thyroid cytopathology and nodules with SUVmax <2.5 are not at increased risk for malignancy.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  235. BRITO JP, Bleyer A
    Impact of thyroid cancer on the incidence and survival of adolescents and young adults with cancer.
    Thyroid. 2016.
    PubMed     Text format    


  236. HIRSCH D, Shohat T, Gorshtein A, Robenshtok E, et al
    Incidence of Non-thyroidal Primary Malignancy and the Association with I-131 Treatment in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  237. GULEC SA, Kuker RA
    The Clinical Value of I-124 PET/CT Imaging in Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format    


  238. SHRESTHA RT, Evasovich MR, Amin K, Radulescu A, et al
    Correlation between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules - A Two Year Institutional Experience.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  239. WHITE MG, Cipriani NA, Abdulrasool L, Kaplan SP, et al
    Radiation Induced Differentiated Thyroid Cancer Is Associated with Improved Overall Survival but Not Thyroid Cancer-Specific Mortality or Disease Free Survival.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  240. JINDAL A, Khan U
    Is Thyroglobulin level by LC-MS/MS always reliable for follow-up of DTC after Thyroidectomy: A report of 2 cases.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  241. PANI F, Atzori F, Baghino G, Boi F, et al
    HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  242. ANDERSON K, Youngwirth L, Scheri R, Stang M, et al
    T1a vs T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  243. CAMPENNI A, Giovanella L, Siracusa M, Alibrandi A, et al
    99mTc-METHOXY-ISOBUTYL-ISONITRILE (MIBI) SCINTIGRAPHY IS A USEFUL TOOL FOR ASSESSING THE RISK OF MALIGNANCY IN THYROID NODULES WITH INDETERMINATE FINE NEEDLE CYTOLOGY (FNAC).
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  244. SHARMA A, Jasim S, Reading CC, Ristow K, et al
    Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma - A Cohort Study.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  245. RUIZ-FERRER M, Fernandez RM, Navarro E, Antinolo G, et al
    The G534E variant in <i>HABP2</i> and Nonmedullary Thyroid Cancer.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    May 2016
  246. KIST JW, de Keizer B, Vogel WV
    Letter to the Editor regarding the article "I-124 PET/CT in patients with differentiated thyroid cancer: clinical and quantitative image analysis".
    Thyroid. 2016.
    PubMed     Text format    


  247. HODAK S, Tuttle RM Md, Maytal G, Nikiforov YE, et al
    Changing the Cancer Diagnosis - the Case of Follicular Variant of Papillary Thyroid Cancer Primum, Non Nocere and NIFTP.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  248. WU JX, Young S, Hung M, Li N, et al
    Clinical Factors Influencing the Performance of Gene Expression Classifier Testing in Indeterminate Thyroid Nodules.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  249. GOLDFARB M, Casillas J
    Thyroid Cancer Specific Quality of Life and Health Related Quality of Life in Young Adult Thyroid Cancer Survivors.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  250. MUJAMMAMI MH, Hier MP, Payne RJ, Rochon L, et al
    Long-term Outcomes of Patients with Papillary Thyroid Cancer undergoing Remnant Ablation with 30 milliCuries Radioiodine.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    April 2016
  251. CAZARIN JM, Coelho RG, Hecht F, Andrade BM, et al
    5 -AMP-activated Protein Kinase (AMPK) Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion and Epithelial-to-Mesenchymal Transition.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  252. LA COUR JL, Andersen UB, Sorensen CH, Nygaard B, et al
    Radioiodine Therapy Does Not Change the Atherosclerotic Burden of the Carotid Arteries.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


  253. HAKALA TT, Kholova I
    Changes in classification of follicular thyroid cancers.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


    March 2016
  254. BRITO JP, Kim HJ, Han SJ, Lee YS, et al
    Geographic distribution and evolution of thyroid cancer epidemic in South Korea.
    Thyroid. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: